title: Regulation of natural killer cell function.
abstract: Individuals lacking natural killer (NK) cells have persistent viral infections and as a consequence die prematurely. In addition, mice with decreased NK cell function are more susceptible to carcinogen-induced cancers. Current evidence strongly suggests that downregulation of MHC by certain tumors and virally-infected cells results in NK cell attack due to the inability to trigger inhibitory Ly49, KIR, and NKG2A/CD94 class Ia and Ib MHC receptors. Extreme haplotype diversity is present in both mouse and human chromosomal segments coding for NK cell class Ia MHC receptors resulting in different numbers and types of receptors being expressed in individuals and different inbred mouse strains. Whether the absence or presence of a particular NK cell receptor gene is advantageous or deleterious for an individual with respect to immunity to pathogens and cancer is a question of paramount importance. Recent advances in our understanding of NK cell function are due to the identification of activating NK cell receptors, such as Ly49H and NKG2D, for specific viral and tumor ligands (m157 and Rae1, respectively). In a clinical setting, such MHC class I receptor diversity is advantageous with respect to preventing leukemic relapse in individuals treated for leukemia and receiving bone marrow transplants. Further delineation of NK cell receptors and tumor ligands will help researchers to exploit the innate immune system to better treat such diseases.
authors.affiliation: Institut de Recherches Cliniques de Montreal, Laboratory of Molecular Immunology, Montreal, Quebec Canada. makriga@ircm.qc.ca
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Makrigiannis
authors.forename: Stephen K
authors.initials: SK
authors.lastname: Anderson
mesh_terms: D000483:Alleles; D000818:Animals; D000950:Antigens, Ly / Q000235:genetics / Q000378:metabolism; D015973:Gene Expression Regulation, Leukemic; D014644:Genetic Variation; D006239:Haplotypes; D015395:Histocompatibility Antigens Class I / Q000378:metabolism; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D037181:Lectins, C-Type; D007938:Leukemia / Q000235:genetics / Q000517:prevention & control; D018448:Models, Immunological; D005810:Multigene Family / Q000276:immunology; D055650:NK Cell Lectin-Like Receptor Subfamily A; D011110:Polymorphism, Genetic; D011971:Receptors, Immunologic / Q000235:genetics / Q000378:metabolism; D055630:Receptors, NK Cell Lectin-Like; D055502:Secondary Prevention
chemical_list: D000950:Antigens, Ly; D015395:Histocompatibility Antigens Class I; C527096:Klra8 protein, mouse; D037181:Lectins, C-Type; D055650:NK Cell Lectin-Like Receptor Subfamily A; D011971:Receptors, Immunologic; D055630:Receptors, NK Cell Lectin-Like